细胞毒性治疗后由骨髓增生异常肿瘤演变而来的急性前体B细胞淋巴细胞白血病：一例报告 - Suppr

Suppr

超能文献

Acute pro-B-cell lymphoblastic leukemia evolving from myelodysplastic neoplasm post cytotoxic therapy: a case report.

作者信息

Wobst Jana, Truger Marietta, Baer Constance, Meggendorfer Manja, Kern Wolfgang, Haferlach Torsten, Haferlach Claudia

机构信息

MLL Munich Leukemia Laboratory, Munich.

出版信息

Haematologica. 2025 Aug 1;110(8):1894-1897. doi: 10.3324/haematol.2025.287357. Epub 2025 Apr 10.

DOI:10.3324/haematol.2025.287357

PMID:40207709

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12358784/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8d6/12358784/bd02079bbaae/1101894.fig1.jpg

相似文献

Acute pro-B-cell lymphoblastic leukemia evolving from myelodysplastic neoplasm post cytotoxic therapy: a case report.

Haematologica. 2025 Aug 1;110(8):1894-1897. doi: 10.3324/haematol.2025.287357. Epub 2025 Apr 10.

Comment on "Acute pro-B-cell lymphoblastic leukemia evolving from myelodysplastic neoplasm post cytotoxic therapy: a case report".

Haematologica. 2025 May 15. doi: 10.3324/haematol.2025.288110.

Exp Mol Pathol. 2017 Dec;103(3):263-266. doi: 10.1016/j.yexmp.2017.11.007. Epub 2017 Nov 16.

A case report of secondary B-cell acute lymphoblastic leukemia treated with a combination of FLT3 inhibitor and decitabine.

Front Oncol. 2024 Apr 26;14:1329279. doi: 10.3389/fonc.2024.1329279. eCollection 2024.

T and NK lymphoblastic leukemia/lymphoma: Report from the 2023 SH/EAHP Workshop.

Am J Clin Pathol. 2025 Jul 11;164(1):26-35. doi: 10.1093/ajcp/aqaf015.

[FGFR1-mutated B-cell acute lymphoblastic leukemia transforming to myelodysplastic / myeloproliferative neoplasm and acute myeloid leukemia].

Rinsho Ketsueki. 2018;59(7):872-877. doi: 10.11406/rinketsu.59.872.

Myelodysplastic syndrome transformed into B-lineage acute lymphoblastic leukemia: A case report.

World J Clin Cases. 2021 Jul 6;9(19):5191-5196. doi: 10.12998/wjcc.v9.i19.5191.

Blinatumomab Therapy Is Associated with Favorable Outcomes after Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients with B Cell Acute Lymphoblastic Leukemia.

Transplant Cell Ther. 2024 Feb;30(2):217-227. doi: 10.1016/j.jtct.2023.10.024. Epub 2023 Nov 4.

Lineage Switch Between B-Lymphoblastic Leukemia and Acute Myeloid Leukemia Intermediated by "Occult" Myelodysplastic Neoplasm: Two Cases of Adult Patients With Evidence of Genomic Instability and Clonal Selection by Chemotherapy.

Am J Clin Pathol. 2017 Aug 1;148(2):136-147. doi: 10.1093/ajcp/aqx055.

B-cell acute lymphoblastic leukemia as a secondary malignancy following diffuse large B-cell lymphoma.

Hematol Rep. 2019 Jun 14;11(2):8100. doi: 10.4081/hr.2019.8100. eCollection 2019 May 23.

本文引用的文献

Acute lymphoblastic leukemia in patients treated with lenalidomide for multiple myeloma: a safety meta-analysis of randomized controlled trials combined with a retrospective study of the WHO's pharmacovigilance database.

Blood Cancer J. 2024 Oct 14;14(1):177. doi: 10.1038/s41408-024-01154-z.

Acute Lymphoblastic Leukemia with Myeloid Mutations Is a High-Risk Disease Associated with Clonal Hematopoiesis.

Blood Cancer Discov. 2024 May 1;5(3):164-179. doi: 10.1158/2643-3230.BCD-23-0106.

Prediction of risk for myeloid malignancy in clonal hematopoiesis.

NEJM Evid. 2023 May;2(5). doi: 10.1056/evidoa2200310. Epub 2023 Apr 25.

Lenalidomide-associated B-cell ALL: clinical and pathologic correlates and sensitivity to lenalidomide withdrawal.

Blood Adv. 2023 Jul 11;7(13):3087-3098. doi: 10.1182/bloodadvances.2022009212.

Second primary malignancies in patients with haematological cancers treated with lenalidomide: a systematic review and meta-analysis.

Lancet Haematol. 2022 Dec;9(12):e906-e918. doi: 10.1016/S2352-3026(22)00289-7. Epub 2022 Oct 27.

International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data.

Blood. 2022 Sep 15;140(11):1200-1228. doi: 10.1182/blood.2022015850.

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.

Leukemia. 2022 Jul;36(7):1703-1719. doi: 10.1038/s41375-022-01613-1. Epub 2022 Jun 22.

What's new in the pathogenesis and treatment of therapy-related myeloid neoplasms.

Blood. 2021 Sep 2;138(9):749-757. doi: 10.1182/blood.2021010764.

Genetics of progression from MDS to secondary leukemia.

Blood. 2020 Jul 2;136(1):50-60. doi: 10.1182/blood.2019000942.

Blood Adv. 2019 Dec 23;3(24):4228-4237. doi: 10.1182/bloodadvances.2019000925.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验